Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

This study has been terminated.

(Loss of funding)

Sponsor:

Collaborator:

Information provided by (Responsible Party):

UNC Lineberger Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00227032

First received: September 23, 2005

Last updated: March 5, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2008
Primary Completion Date:	February 2008 (Final data collection date for primary outcome measure)